• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Post-infectious immune suppression: A new paradigm of severe infections

tetano

Editor, Senior Moderator
Med Mal Infect. 2014 Aug 25. pii: S0399-077X(14)00194-2. doi: 10.1016/j.medmal.2014.07.017. [Epub ahead of print]
Post-infectious immune suppression: A new paradigm of severe infections.
Grimaldi D1, Llitjos JF2, P?ne F3.
Author information
Abstract

Infectious diseases remain a major public health issue in both developing and developed countries. For instance, there is still a high rate of morbidity and mortality due to seasonal influenza outbreaks and severe bacterial sepsis, despite major advances in their prevention and treatment. It is now clear that severe influenza and bacterial infections promote susceptibility for superinfections worsening the prognosis. Various immune defects acquired during severe infection may result in complex immunosuppression and may affect both innate and adaptive components. Some animal models of these common clinical situations have demonstrated the increased susceptibility of infected hosts to secondary infectious insult and allowed assessing the regulatory mechanisms. Such pathophysiological advances may help create new immunomodulatory therapeutics for infected patients exposed to severe secondary sepsis.

Copyright ? 2014 Elsevier Masson SAS. All rights reserved.
KEYWORDS:

Grippe; Immunod?pression post-infectieuse; Immunotherapy; Immunoth?rapie; Infection secondaire; Influenza; Sepsis grave; Sepsis-induced immunosuppression; Severe sepsis; Superinfection

PMID:
25169939
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25169939
 
Back
Top Bottom